Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma

Digestive Diseases and Sciences

Volumn 56, Issue 3, 2011, Pages 681-688

  He, Yuanlong ^a   Wang, Yongjun ^a   Li, Peng ^a   Zhu, Shengtao ^a   Wang, Junxiong ^a   Zhang, Shutian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Esophageal squamous cell carcinoma; GPX3; Microarray analysis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GLUTATHIONE PEROXIDASE 3; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METHYLATION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 79952444349     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1369-0     Document Type: Article

References (18)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 57 70 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10.1016/S0092-8674(00)81683-9 10647931 (Pubitemid 30046295)
3. BA Ponder 2001 Cancer genetics Nature 411 336 341 1:CAS:528: DC%2BD3MXktVSjsr4%3D 10.1038/35077207 11357140 (Pubitemid 32467042)
4. LW Li XY Yu Y Yang CP Zhang LP Guo SH Lu 2009 Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo Int J Cancer 125 1505 1513 1:CAS:528:DC%2BD1MXpsVKmtr4%3D 10.1002/ijc.24513 19521989
5. I Salam S Hussain MM Mir, et al. 2009 Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area Mol Cell Biochem 332 51 58 1:CAS:528: DC%2BD1MXhtlKjs7zN 10.1007/s11010-009-0173-7 19513816
6. BJ Zhao SN Tan Y Cui DG Sun X Ma 2008 Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma Dis Esophagus 21 582 588 10.1111/j.1442-2050.2007.00808.x 19040536
7. TJ Seng JS Low H Li, et al. 2007 The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation Oncogene 26 934 944 1:CAS:528:DC%2BD2sXhsVersbs%3D 10.1038/sj.onc.1209839 16862168
8. J Yu Q Tao KF Cheung, et al. 2008 Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors Hepatology 48 508 518 1:CAS:528:DC%2BD1cXhtVCqt7vN 10.1002/hep.22343 18666234
9. D Oka S Yamashita T Tomioka, et al. 2009 The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers Cancer 115 3412 3426 1:CAS:528:DC%2BD1MXpslOntbg%3D 10.1002/cncr.24394 19472401
10. PW Laird 2003 The power and the promise of DNA methylation markers Nat Rev Cancer 3 253 266 1:CAS:528:DC%2BD3sXisFajtL4%3D 10.1038/nrc1045 12671664 (Pubitemid 37328861)
11. PA Jones SB Baylin 2002 The fundamental role of epigenetic events in cancer Nat Rev Genet 3 415 428 1:CAS:528:DC%2BD38XksFOmsrw%3D 10.1038/nrg962 12042769 (Pubitemid 34587077)
12. CD Jee MA Kim EJ Jung J Kim WH Kim 2009 Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma Eur J Cancer 45 1282 1293 1:CAS:528:DC%2BD1MXktlyqtLw%3D 10.1016/j.ejca.2008.12.027 19195878
13. K Milde-Langosch AM Bamberger G Rieck B Kelp T Löning 2001 Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype Breast Cancer Res Treat 67 61 70 1:CAS:528:DC%2BD3MXms1SiurY%3D 10.1023/A:1010623308275 11518467 (Pubitemid 32703389)
14. YP Yu G Yu G Tseng, et al. 2007 Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis Cancer Res 67 8043 8050 1:CAS:528:DC%2BD2sXpvFKjtL4%3D 10.1158/0008-5472.CAN-07- 0648 17804715 (Pubitemid 47395138)
15. DF Peng M Razvi H Chen, et al. 2009 DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma Gut 58 5 15 1:CAS:528: DC%2BD1MXhs1SktL8%3D 10.1136/gut.2007.146290 18664505
16. OJ Lee R Schneider-Stock PA McChesney, et al. 2005 Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis Neoplasia 7 854 861 1:CAS:528:DC%2BD2MXhtlClurfO 10.1593/neo.05328 16229808
17. MK Kashyap A Marimuthu CJ Kishore, et al. 2009 Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers Cancer Biol Ther 8 36 46 1:CAS:528:DC%2BD1MXptVentbc%3D 18981721
18. Wang JY, Yang IP, Wu DC, et al. Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwanese patients with gastric cancer. Clin Chim Acta 2010 May 27. [Epub ahead of print].